ZURICH (Reuters) – Novartis said it resumed the production and delivery of radioligand therapy medicines after fixing the issues that had led to a temporary suspension of...
The pharmaceutical giant is cutting up to 7% of its global workforce, with the layoffs particularly affecting 1,400 positions at its operations in Switzerland.
The Swiss pharmaceutical giant’s job cuts, including 1,400 in Switzerland, are part of a previously disclosed restructuring plan aimed at saving some $1 billion in costs.
LONDON, July 05, 2022 (GLOBE NEWSWIRE) -- The “Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update” report offered by...
The big pharmaceutical companies have always tended to generate a somewhat mixed response when discussed in the wider context of stock picking.The sector has had a fairly...
The big pharmaceutical companies have always tended to generate a somewhat mixed response when discussed in the wider context of stock picking.The sector has had a fairly...
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Neutral | Neutral | Strong Sell | Sell |
| Technical Indicators | Strong Sell | Strong Buy | Sell | Buy | Sell |
| Summary | Strong Sell | Buy | Neutral | Neutral | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,321.00 | 1,331.00 | 1,270.00 | +16.00 | +1.23% | 29.83K | London | |||
| 1,758.50 | 1,825.00 | 1,740.50 | -106.5 | -5.71% | 359.28K | London | |||
| 0.75 | 0.80 | 0.722 | 0.0000 | 0.00% | 2.41M | London | |||
| 78.10 | 78.18 | 77.38 | +1.70 | +2.23% | 1.39M | London | |||
| 79.30 | 81.50 | 79.30 | -1.50 | -1.86% | 57.64K | London | |||
| 1.3766 | 1.3766 | 1.3766 | +0.0250 | +1.82% | 6.70M | London | |||
| 1,132.50 | 1,131.50 | 1,109.50 | +4.50 | +0.40% | 64.49K | London | |||
| 240.47 | 240.70 | 237.00 | +7.30 | +3.13% | 2.19M | London | |||
| 103.00 | 99.70 | 71.00 | 0.00 | 0.00% | 0.00 | London | |||
| 8.52 | 8.99 | 8.50 | -0.34 | -3.84% | 5.30K | London | |||
| 2.72 | 2.72 | 2.72 | +0.35 | +14.00% | 4.77M | London | |||
| 190.40 | 190.80 | 189.20 | +2.70 | +1.44% | 157.64K | London | |||
| 113.08 | 113.08 | 113.08 | +8.00 | +7.58% | 175.87K | London | |||
| 811.00 | 833.00 | 787.50 | +19.50 | +2.47% | 75.87K | London | |||
| 89.01 | 90.00 | 87.90 | +1.10 | +1.25% | 226.10K | London |